Colonic mucus bacterial communities are critical for determining disease pathology and promoting colonization resistance. Yet the key ecological properties of mucus resident communities that make them crucial for maintaining homeostatic microbiome function remain poorly defined. Using an approach that combines in situ hybridization, laser microdissection and 16s rRNA sequencing of spatially distinct regions of the mouse gut lumen, we discovered that the microbial community embedded in the mucus layer is structurally and compositionally distinct and drives stability of the gut microbiome. Structurally, the mucus residing microbial community had a higher density of bacteria than in the lumen and formed a biofilm-like structure whose integrity was dependent on Gram-positive commensals. Compositionally the dense mucus community excluded bacteria belonging to phylum Proteobacteria. Additionally, the dense bacterial community in the mucus was significantly more diverse and consisted of bacterial species that were unique to it. Upon antibiotic treatment, the species-rich and dense bacterial community in the mucus lost fewer Firmicutes and showed smaller bloom of Proteobacteria compared to the lumen. Taken together our work discloses a crucial role for the mucus layer in promoting stability of the gut microbiome in the perfused intestinal ecosystem by spatially entrenching unique and diverse bacterial species.
Introduction
The past two decades have been a golden age for microbiome research. Exhaustive efforts to characterize the human and experimental animal microbiome coupled with exciting advances in sequencing technologies and computational techniques have immensely enhanced our knowledge about the diversity of the host-associated microbiome. By comparing microbial composition between different physiologic states it has become clear that various aspects of host physiology, metabolism, and immune system are intimately linked to the microbes and their interactions with the host (Integrative, 2014) . Accordingly, the gut microbiome has been shown to play causative role in the most prominent diseases of modern times, including inflammatory bowel diseases (IBD) such as Crohn's and ulcerative colitis, colon cancer and metabolic diseases such as diabetes and obesity (Cho and Blaser, 2012) . However, attempts to identify a common pattern of microbial dysbiosis linked with these diseases have failed. Recently, multiple studies have shown that bacterial communities in the gut are spatially organized and disrupted spatial organization of the gut microbiome is often a common underlying feature of disease pathogenesis. As a result, focus over the last few years has shifted towards understanding gut microbiome dysbiosis in spatial context as a feature of microbiome associated diseases from just cataloging the diversity of gut bacteria (Donaldson et al., 2016) . This line of investigation has brought the role of microbial communities overlying the intestinal mucus in promoting disease into sharp focus. A study involving the largest cohort of pediatric Crohn's disease patients demonstrated that assessing the mucus-associated microbiome compared to fecal communities is more effective in early diagnosis of disease (Gevers et al., 2014) . Isolation of colonic mucus from mice mono-colonized with specific commensals showed that bacterial species present in the mucus show differential proliferation and resource utilization compared with the same species in the intestinal lumen of mice (Li et al., 2015) . In both mouse and human it was shown that mucus-associated communities were distinct and not represented by fecal communities (Zmora et al., 2018) . Moreover, mucosal communities were refractory to colonization by probiotics unless perturbed by antibiotics (Suez et al., 2018) . Although these studies underscore the critical role of mucus residing communities in determining disease pathology and promoting colonization resistance, ecological features of mucus resident communities that confer these properties remain poorly defined.
To fill this gap in our understanding of the gut microbiome ecology, we developed a novel strategy that combines fluorescence in-situ hybridization (FISH) with the spatial dissection power of laser capture microdissection (LCM) and 16S microbiome sequencing. We found that the microbial community closest to the host overlying the dense mucus layer forms a unique biofilm-like structure that harbors significantly higher species richness, selectively excluding bacteria belonging to class Gammaproteobacteria and is resistant to antibiotic induced dysbiosis. We propose that this community represents a previously unrecognized ecological safe harbor that promotes gut microbial homeostasis.
Results
Bacteria overlying the colonic mucus form biofilm-like structure that resists perturbation caused by broad spectrum antibiotic but not narrow spectrum antibiotic.
Fluorescence in-situ hybridization (FISH) to 16s rRNA in combination with specialized tissue fixation methodologies that preserve mucus structure in an intact state enable the observation of microbe-microbe and host-microbe relationships in-situ (Johansson et al., 2008; Mark Welch et al., 2016; Vaishnava et al., 2011) . To understand the landscape of bacterial communities residing within the gut, we analyzed in the transverse sections of mouse colon using universal 16s rRNA FISH probes ( Figure 1A ). Quantification showed that the dense community extends up to 29 μ m into the lumen forming a biofilm-like structure ( Figure 1B) . The biofilm resided immediately adjacent to the sterile, dense mucus layer ( Figure 1C ), which was on average 17μm thick in mice from our colony at Brown University ( Figure 1D ). To see if the biofilm-like structure close to the host was specific to mice in our colony, we evaluated the spatial organization of mice from Jackson Laboratories. We found that even though mice from Jackson had a thinner dense mucus layer (average 4.6μm) they still had a similar biofilm-like community structure adjacent to the dense mucus layer that extends up to 33 μ m ( Figure S1 ). A similar dense community has previously been described in the colon of gnotobiotic mice colonized with a defined 15-member community (Mark Welch et al., 2017) suggesting that this is a conserved feature of gut microbial community organization.
In order to assess the contribution of community composition in the maintenance of the biofilm-like structure, we subjected it to perturbation by a broad (Ciprofloxacin) and narrow (Vancomycin) spectrum antibiotic ( Figure S2A ). Comparison of fecal communities of mice treated with Vancomycin or Ciprofloxacin to that of untreated communities confirmed that both antibiotics significantly decreased the diversity of the microbiome, a characteristic of antibiotic treatment ( Figure S2B ). The mice treated with Vancomycin experienced a larger disruption in fecal community composition compared to those treated with Ciprofloxacin ( Figure S2C ).
Vancomycin treatment as expected resulted in a significant depletion of Clostridia and an expansion of Gammaproteobacteria (Table S1 and S2). To determine if differences in community composition between Ciprofloxacin and Vancomycin treatments correlated with differences in community structure, we employed FISH to visualize the gut microbiome in-situ.
Ciprofloxacin treated communities maintained the biofilm-like structure similar to that seen in untreated mice, whereas this community structure was completely lost in mice treated with Vancomycin ( Figures 1E, 1F and 1G ). The Ciprofloxacin-treated mice were devoid of Proteobacteria whereas the remaining community in Vancomycin-treated mice harbored members of Proteobacteria ( Figures 1E, 1F, 1H ). Additionally, Clostridia were preserved within the biofilm community upon Ciprofloxacin treatment, but lost after Vancomycin treatment (Figures 1E , 1F and 1I ) . Obliteration of the biofilm-like structure was inversely correlated with the presence of Clostridia within the dense community. These data suggest that vancomycinsensitive microbes such as Clostridia are important for maintaining community structure.
Mucus associated biofilm community is compositionally distinct from adjoining nonbiofilm community.
To assess the microbial composition of the bacterial community in the mucus biofilm we adapted laser-capture microdissection (LCM) technique to isolate defined regions of the colonic mucus layer followed by 16S rRNA sequencing. The LCM isolation strategy was designed so as to capture the first 100μm from the epithelial lining (corresponding to the observed thickness of the biofilm) (inner) independently of the adjoining 50μm section of non-biofilm community (outer) (Figure 2A-B ). Using this strategy, we collected an area of 1,000,000 μ m 2 of the inner community and corresponding 500,000μm 2 of the outer community for each mouse colon.
qPCR quantification of the community samples confirmed that the inner biofilm community had higher bacterial load compared to the outer non-biofilm community ( Figure 2C ). We applied similar dissection strategy to colonic tissue sections from germ-free(GF) mice to ensure that the LCM procedure did not introduce any bacterial DNA contamination ( Figure S3 ). We isolated the inner biofilm and outer non-biofilm communities from mice from two different cages and compared microbiome dissimilarities based on cage and location (inner vs outer). We used the distance metric UniFrac that uses phylogenetic relationships to evaluate differences in overall composition between communities (Lozupone and Knight, 2005) . Using weighted UniFrac distances that calculates dissimilarities in abundance of microbes (quantitative), we only saw a difference in community composition between the two cages but no difference was noted between the two locations ( Figure 2D Left) . The unweighted analysis that calculates dissimilarity based on presence or absence of a microbe (qualitative) showed that location was the second most contributing variable that significantly separated the biofilm community from the adjacent non-biofilm community (Axis 2) (Figure 2D Right). Evaluating composition without abundance indicates differences in communities is based on which taxa are able to live in them (Lozupone et al., 2007) . Differential abundance analysis at class level revealed that the biofilm community just like the non-biofilm community comprised mainly of bacteria belonging to class Bacteroidia and Clostridia. However, the non-biofilm community harbored significantly more Gammaproteobacteria compared to the biofilm community ( Figure 2E -F). These results suggest that Gammaproteobacteria are selectively restricted from colonizing the mucus layer closest to the host epithelium.
Biofilm community closest to the host has significantly higher species richness due to presence of low abundance unique amplicon sequence variants (ASVs).
Diversity is one of the most important ecological attributes which determines stability of a community (Smith, 2007) . The number of species represented in an ecosystem (its richness) and the way in which individuals are distributed amongst the species (its evenness) are often combined into a single index to quantify diversity. Plotting the number of unique amplicon sequence variants (ASVs) found at increasing subsampling depths with an alpha rarefaction curve showed that the biofilm community consistently had more unique observed ASVs ( Figure   3A ). Using the Chao1 index that estimates true community richness, we saw the inner community that corresponds with the biofilm has significantly higher species richness ( Figure   3B ). Species evenness in a community captures another aspect of diversity by determining diversity as a standardized index of relative species abundance. We evaluated the evenness of the two communities by applying Pielou's evenness index (Pielou, 1969) and found the biofilm community is significantly less even than the non-biofilm community ( Figure 3D ). Accordingly, Shannon-Weaver, a commonly used diversity index that takes into account both richness and evenness of communities, showed no difference between the two communities. ( Figure 3C ).
Given the high alpha diversity in the inner community, we hypothesized that the inner community might harbor microbial species that are not found in the outer community. To test this, we determined the number of ASVs that were unique or shared between the inner biofilm and outer non-biofilm community within each mouse. We found in each animal significantly more ASVs were unique to the biofilm (average 70% unique, 30% shared) ( Figure 3E ) whereas the adjoining non-biofilm region comprised of more shared ASVs (30% unique and 70% shared). Bacteroidia and Clostridia made up the majority of bacteria that are unique or shared in both communities ( Figure 3F ). Additionally, at family level unique microbes made up a very small percent (<0.2%) of the total abundance within the biofilm community ( Figure 3G ).
Conversely, microbes shared between the two locations were highly abundant within the biofilm ( Figure S4 ). We believe that although unique mucus-associated bacteria are seeded from the luminal microbes, many microbial species in the lumen community might be too scarce to be captured by sequencing. As a result we detect these low abundant microbial species only when their relative abundance increases during biofilm formation. Thus our results demonstrate that mucus associated biofilms represent a novel species bank of hidden microbial diversity and functional potential in the gut.
Mucus residing biofilm community maintains higher species richness and is less prone to dysbiosis than luminal community following antibiotics
Uneven distribution or spatial heterogeneity of species within an ecosystem increase its stability during large scale perturbations (Wang and Loreau, 2014) . We wanted to assess whether the spatial heterogeneity we observe within the gut mucosal community contributes to its stability. Mice from Jackson laboratories were subjected to a clinically relevant vancomycin treatment for 10 days (Sekirov et al., 2008)( Figure 4A ). Taking into account the thinner mucus layer in Jackson mice, ( Figure S1 ), we isolated the 50μm section closest to the intestinal epithelium. Luminal community was isolated by excising a 300μm diameter circle from the center of the cross section. Antibiotic treatment significantly altered the biofilm as well luminal communities ( Figure 4B -C). Before antibiotic treatment communities in both locations had similar richness, however following antibiotic treatment the mucus biofilm community lost significantly less richness than luminal communities ( Figure 4D ). The greater impact of antibiotic treatment on species richness in the luminal community suggests the biofilm community is less susceptible to antibiotic perturbation. Additionally, after antibiotic treatment, we saw an increase in the relative abundance of Proteobacteria and a decrease in the relative abundance of Firmicutes in the luminal community compared to the biofilm community ( Figure 4E ).
Specifically, we saw that post antibiotic treatment, the differential abundance of Clostridia was significantly more in the biofilm than the lumen community ( Figure 4F ). In contrast, a larger bloom β -Proteobacteria was observed in the lumen compared to the biofilm ( Figure 4G ).
Quantification with qPCR and Clostridia specific 16s rRNA FISH further confirmed that after antibiotic treatment significantly more Clostridia are preserved within the biofilm compared to lumen ( Figure 4H -I).
Discussion
Biofilms constitute the dominant mode of microbial life in most ecosystems (Costerton et al., 1995; Hall-Stoodley et al., 2004 ) yet they remain poorly described in the gut that harbor dense consortium of commensal bacteria. To characterize complex gut biofilms, we used a classical histological procedure to preserve mucus integrity, specific techniques for microbiota detection (i.e., FISH) and UV-laser assisted dissection of biofilm communities in micron scale for 16s rRNA microbiome analysis. Our method using entire cross sections of mouse colon fixed in Carnoy's fixative to preserve mucus architecture allowed us to survey the structure and spatial composition of the gut microbiome as it exists in-situ. We saw that intestinal bacteria form a continuous biofilm, lining the mucus surface that coats the colonic mucosa. Biofilm structure was stable when treated with Ciprofloxacin, a broad-spectrum antibiotic, but collapsed completely when treated with Vancomycin that targets commensals belonging to class Clostridia. Collapse of biofilm structure coincided with bloom of Proteobacteria near the mucus.
Our observation that mucus associated biofilm in the murine colon is a normal feature is in contrast to studies that associate intestinal biofilms with pathogenic phenotypes such as IBD and colon cancer (Dejea et al., 2018; Swidsinski et al., 2005) . However in these studies it was noted that the biofilms associated with diseased pathology had higher concentration of pathobionts such as Bacteroides fragilis, E.coli and Fusobacterium nucleatum compared to controls. Moreover, biofilms from patients with Crohn's disease or with ulcerative colitis were shown to be disrupted, allowing pathobionts to spread and invade intestinal epithelia and cause inflammation (Motta et al., 2018) . Thus, indicating that it is not the biofilm phenotype per se that drives the disease phenotype but structural and functional disruption of intestinal biofilms that drives disease pathogenesis in the gut. In fact, mucus associated biofilms provide an efficient strategy for commensals to resist environmental perturbations, the host immune system, and luminal flow in the GI tract and thus promote stability of the gut microbiota (Dunne, 2002) .
Additionally, close proximity of mucus associated biofilms benefit the host by modulating immunity and acting as deterrent to colonization and invasion by enteropathogens (Round and Mazmanian, 2009).
Using antibiotics with different targets we found that the "narrow-spectrum" antibiotic induced the largest changes in biofilm structure and the loss of biofilm structure was correlated with ablation of Clostridia and the expansion of Proteobacteria. These results suggest that "narrow-spectrum" and "broad-spectrum" require new definitions that go beyond understanding how antibiotics specifically target certain organisms, and incorporate how they affect community architecture. A number of healthy people naturally carry Clostridium difficile in their large intestine and don't have ill effects from the infection (Taylor et al., 1981) . C.difficile infection in humans are associated with recent antibiotic use (De La Cochetiere et al., 2008) . Once infected, C.difficile is known to form biofilms in the gut that resist antibiotic treatment (Ethapa et al., 2013) . It would be important to understand whether the adverse effect of an antibiotic regimen on the commensal biofilm is directly correlated with susceptibility to C.difficile infection. Also equally important to determine would be whether fecal microbiota transfer (FMT) that corrects C.difficile infection restores homeostatic commensal biofilm.
16s rRNA microbiome analysis of the bacterial community micro-dissected from the biofilm revealed that Gammaproteobacteria, a bacterial class associated with antibiotic induced dysbiosis, are in much lower abundance in the biofilm compared to adjoining areas. In a healthy gut, members of phylum Proteobacteria are normally maintained at very low levels but expand significantly in dysbiosis (Le Bastard et al., 2018; Rivera-Chavez et al., 2017) . Increased abundance of class Gammaproteobacteria is seen in metabolic disorders (Larsen et al., 2010; Qin et al., 2012) , obesity (Fei and Zhao, 2013; Sen et al., 2017) , and inflammatory bowel disease (Gevers et al., 2014) , all pathologies characterized by intestinal inflammation (Sen et al., 2017) . Our results suggest that biofilm structure rich in anaerobic commensals such as Clostridia suppress Proteobacteria bloom. Depletion of Clostridia within the biofilm is coincident with Proteobacteria bloom. We also found that antibiotic induced depletion of species richness and associated dysbiosis was significantly lower in biofilm compared to the lumen communities.
Several studies show that biofilm-grown cells have properties that are distinct from planktonic cells, one of which is an increased resistance to antimicrobial agents (Donlan, 2002) . Work on in-vitro biofilms show that slow growth and/or induction of an rpoS-mediated stress response could contribute to antimicrobial resistance (Prigent-Combaret et al., 1999) . Moreover, the physical and/or chemical structure of mucus where the biofilms are embedded could also confer resistance by exclusion of antibiotics from the bacterial community. Finally, bacteria growing as biofilm might develop a specific antibiotic-resistant phenotype (Olsen, 2015) . It is likely that there are multiple resistance mechanisms at work that confer this property to mucus biofilms and future work looking at meta-transcriptional response of mucus associated biofilms in health and disease would be crucial in further delineating these properties.
Mechanisms regulating the biofilm formation of commensal bacteria are yet to be fully elucidated. Whether these mechanisms are bacteria or/and host intrinsic remains to be seen.
Bacterial intrinsic mechanisms such as expression of Serine-Rich Repeat Proteins (SRRP's) that bind to host epithelial proteins in pH-dependent manner can be foreseen in helping biofilm formation in different niches of the gut (Frese et al., 2013; Sequeira et al., 2018) . Another bacterial intrinsic mechanism that could be crucial for biofilm formation is a mode of biochemical communication between different bacteria species called quorum sensing. The role of quorum sensing has been well established in forming biofilms in several bacterial species, including E. coli, P. aeruginosa, and Salmonella sp. (Valentini and Filloux, 2016) . Quorum sensing between different species of gut commensals was recently shown to influence the abundance of the major phyla of the gut microbiota (Thompson et al., 2015) . On the host side, several innate and adaptive immune effectors that are continuously secreted into the gut lumen could play a role in entrenching the biofilm in the intestinal mucus. Whether the huge quantity of IgA that is secreted into the gut lumen contributes to complex biofilm formation requires further research. Recently it was shown that in vivo coating with IgA promotes aggregation of commensal bacteria B.fragilis within the mucus (Donaldson et al., 2018) . A different study linked IgA binding to bacteria within the mucus layer of the colon to transcriptional changes that stabilize in microbial consortium (Nakajima et al., 2018) . Gut epithelium also secretes a slew of antimicrobial proteins that are important for regulating spatial organization of bacteria that could play a critical role in biofilm formation. For example, RegIIIγ, a c-type lectin that specifically targets Gram positive bacteria regulates host-microbe spatial segregation in the small intestine could promote biofilm structure by maintaining immune tolerance of microbial communities close to the epithelium (Vaishnava et al., 2011) . A small lectin-like protein ZG16 (zymogen granulae protein 16) secreted by the host was recently shown to aggregate bacteria in the colonic mucus layer to maintain bacteria at a safe distance from the epithelial cell surface (Bergstrom et al., 2016) . Finally, epithelium secreted effector Ly6/PLAUR domain containing 8 (Lypd8) protein binds flagellated microbiota and keeps them away from epithelium (Okumura et al., 2016) . These and other discoveries on the mechanisms orchestrating the gut microbiota spatial organization should be evaluated for their role in promoting homeostatic biofilms in the gut. Determining mechanisms that promote or disrupt homeostatic biofilm structure in gut should help towards identifying novel therapeutic targets in a broad variety of disorders mediated by microbiota biofilm dysbiosis.
STAR Methods

Contact for Reagent and Resource Sharing
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Dr. Shipra Vaishnava (shipra_vaishnava@brown.edu).
Experimental Model and Subject Details
Mice
All mice used were wild-type with a C57BL/6 background. Mice used for homeostatic characterization were bred in the SPF barrier facility at Brown University and sacrificed at 8 weeks of age. 6 mice were male, all littermates and kept in the same cage. The other 5 were female from two different litters and kept in the same cage post-weaning (cage-mates). Mice used for characterization of spatial organization in Jackson mice were ordered from Jackson Laboratories, consisting of 3 males and 3 females and sacrificed at 6 weeks of age. Mice used for comparing mucosal and luminal communities after antibiotic treatment were ordered from Jackson Laboratories, consisting of 15 6-week old female cage-mates. Mice used for comparing Ciprofloxacin and Vancomycin antibiotic treatment were ordered from Taconic Biosciences, consisting of 12 7-week old female cage-mates. Experiments were performed according to protocols approved by the Institutional Animal Care and Use Committees of Brown University.
Antibiotics Experiments
Experiment comparing Vancomycin and Ciprofloxacin antibiotic treatment was done by exchanging drinking water with either 500mg/L Vancomycin or 500mg/L Ciprofloxacin (pH 11).
Mice were sacrificed after 3 days of treatment. Experiment comparing mucosal and luminal communities after antibiotic treatment was done by exchanging drinking water with 100mg/L Vancomycin. Mice were sacrificed after 10 days of treatment.
Method Details
Sample Preparation
The distal colon was carefully removed to avoid disrupting architecture of encased contents and placed in 3mL Methacarn for 24 hours. Tissues were washed 3x over 3 days with 70% EtOH at 4°C. Tissues were processed at the Brown University Molecular Pathology Core with the Leica ASP300S by first dehydrating (70% EtOH 1 hr, 2 washes 95% EtOH 45 min, 1 hr, 3 washes 100% EtOH 45 min, 1 hr, 1 hr) then infiltrated with xylenes (3 washes, 45 min, 45 min, 1 hr) followed by paraffin wax at 60°C (1 hr, 1 hr, 1hr 15 min). Samples were embedded in paraffin to produce cross sections by holding tissues vertically in a base of hot wax while chilling. Once wax base secured the tissue vertically, the cassette was filled the rest of the way and chilled until hard.
Fluorescence in-situ hybridization and MFI Quantification
7-μm thick slides were deparaffinized through a solution series for 10 minutes each (xylenes, xylenes, 100% EtOH, 95% EtOH, 70% EtOH, H 2 O). Slides were placed in a pre-warmed (56°C) humidifying chamber and incubated 10 minutes with pre-warmed hybridization buffer (0.9M NaCl, 20mM Tris pH 7.4, 0.1% SDS). Hybridization buffer was removed and pre-warmed probe solutions were applied to regions of tissue isolated with hydrophobic slider marker. Probe solutions were prepared using 2μL EUB338I (1μg/μL), 2μL EUB338II ( 
Erec482 (1μg/μL), 30μL formamide, and 60μL hybridization buffer per slide for viewing all bacteria (green) and Clostridia (red) (Franks et al., 1998; Lay et al., 2005) . Incubated slides at 56°C with probe solutions in humidifying chamber for 4 hours. Washed slides twice for 10 minutes in wash buffer (0.9M NaCl, 20mM Tris pH 7.4). Incubated slides with DAPI (1μg/mL) 10 minutes, followed by a final wash in wash buffer for 10 minutes. Dried slides 10 minutes at 56°C before applying coverslip with Fluro-Gel. Mean Fluorescence Intensity (MFI) measurements were taken using a Zeiss Inverted Microscope (Axio Observer Z1) using the profile function within the AxioVision Rel. 4.8 software to take the average MFI of the default 10-μm wide area, starting 10μm prior to the presence of bacteria and 40μm into the luminal space. 20 measurements were taken per mouse, taking 4 measurements from 5 different cross sections to obtain an average. Confocal images were taken on an Olympus FV3000 confocal microscope.
Mucus Thickness
7-μm thick slides were deparaffinized through a solution series for 5 minutes each (xylenes, xylenes, 100% EtOH, 95% EtOH, 75% EtOH, H 2 O). Alcian Blue/Pas staining was done using the protocol outlined in "Histotechnology: A Self-Instructional Text, 3 rd edition. Pages 115-116".
Slides were stained with Alcian Blue for 30 minutes, washed with running tap water for 2 minutes followed by a rinse with deionized (DI) water. Slides were stained with 0.5% Periodic acid for 5 minutes, washed with DI, then stained with Schiff's Reagent for 30 minutes followed by a rinse with running tap water for 3 minutes. Nuclei were stained with Hematoxylin for 2 minutes, washed with running water for 30 seconds, followed by 10 dips in Clarifier, another 30 second wash, 10 dips in Bluing Reagent, and a final 30 second wash. Slides went through a solution series for 5 minutes each (95% EtOH, 100% EtOH, Xylenes, Xylenes). Coverslips were applied with Cytoseal and slides were allowed to dry overnight in the fume hood. The dense mucus layer of 40 locations evenly distributed from available cross sections on the slide (4-8 cross sections) were measured for each mouse at 60X magnification to obtain the average mucus thickness for each mouse, then combined to obtain the overall average and standard deviation.
Laser Capture Microdissection (LCM) and DNA extraction
Tissues were sectioned at 12μm and placed on Arcturus PEN Membrane Frame Slides and kept at 56°C overnight. Slides were deparaffinized through a solution series for 3 minutes each (xylenes, xylenes, 1:1; xylenes: EtOH, 100% EtOH, 100% EtOH, 95% EtOH, 70% EtOH, 50%
EtOH, H 2 O). Slides were stained with Alcian Blue (1 min 
Quantification and Statistical Analysis
Differences between groups of communities was calculated using a permutational multivariate analysis of variance (PERMANOVA) based on UniFrac distance (Lozupone and Knight, 2005 I. FISH images of mucosal communities before and after Vancomycin treatment showing the greater prevalence of Clostridia (red) before treatment and the reduction after antibiotics, and the greater maintenance of Clostridia in the biofilm-like structure adjacent to the host epithelium (blue) following treatment.
